To assess the effects of the ECM and CML-ECM in the survival of fibroblasts, we quantified the expression of anti-apoptotic BCL2 gene transcripts in fibroblasts treated with media, the ECM, and the CML-ECM. Here, BCL2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.